Publicacións nas que colabora con María Pardo Pérez (17)

2022

  1. Platelet Lipidome Fingerprint: New Assistance to Characterize Platelet Dysfunction in Obesity

    International Journal of Molecular Sciences, Vol. 23, Núm. 15

2021

  1. Phosphoproteomic Analysis of Platelets in Severe Obesity Uncovers Platelet Reactivity and Signaling Pathways Alterations

    Arteriosclerosis, Thrombosis, and Vascular Biology, Vol. 41, Núm. 1, pp. 478-490

2020

  1. Analysis of platelets from a diet-induced obesity rat model: elucidating platelet dysfunction in obesity

    Scientific Reports, Vol. 10, Núm. 1

2019

  1. A Combination of Proteomic Approaches Identifies A Panel of Circulating Extracellular Vesicle Proteins Related to the Risk of Suffering Cardiovascular Disease in Obese Patients

    Proteomics, Vol. 19, Núm. 1-2

  2. Data on hyper-activation of GPVI signalling in obese patients: Towards the identification of novel antiplatelet targets in obesity

    Data in Brief

  3. GPVI surface expression and signalling pathway activation are increased in platelets from obese patients: Elucidating potential anti-atherothrombotic targets in obesity

    Atherosclerosis, Vol. 281, pp. 62-70

2017

  1. In Vitro Evaluation of the Ophthalmic Toxicity Profile of Chlorhexidine and Propamidine Isethionate Eye Drops

    Journal of Ocular Pharmacology and Therapeutics, Vol. 33, Núm. 3, pp. 202-209

  2. In vivo eye surface residence determination by high-resolution scintigraphy of a novel ion-sensitive hydrogel based on gellan gum and kappa-carrageenan

    European Journal of Pharmaceutics and Biopharmaceutics, Vol. 114, pp. 317-323

  3. Positron emission tomography for the development and characterization of corneal permanence of ophthalmic pharmaceutical formulations

    Investigative Ophthalmology and Visual Science, Vol. 58, Núm. 2, pp. 772-780

2016

  1. Evaluation of the in vitro ocular toxicity of the fortified antibiotic eye drops prepared at the hospital pharmacy departments

    Farmacia Hospitalaria, Vol. 40, Núm. 5, pp. 352-370

2015

  1. Ocular safety comparison of non-steroidal anti-inflammatory eye drops used in pseudophakic cystoid macular edema prevention

    International Journal of Pharmaceutics, Vol. 495, Núm. 2, pp. 680-691

2014

  1. Cyclodextrin-polysaccharide-based, in situ-gelled system for ocular antifungal delivery

    Beilstein Journal of Organic Chemistry, Vol. 10, pp. 2903-2911

2012

  1. III Jornadas Bienales de Jóvenes Investigadores en Proteómica, Santiago de Compostela 2012: una visión de futuro y optimismo ante un horizonte incierto

    Proteómica: revista de la Sociedad Española de Proteómica, Núm. 8, pp. 13-14

2007

  1. Biomarker discovery from uveal melanoma secretomes: Identification of gp100 and cathepsin D in patient serum

    Journal of Proteome Research, Vol. 6, Núm. 7, pp. 2802-2811

2006

  1. The characterization of the invasion phenotype of uveal melanoma tumour cells shows the presence of MUC18 and HMG-1 metastasis markers and leads to the identification of DJ-1 as a potential serum biomarker

    International Journal of Cancer, Vol. 119, Núm. 5, pp. 1014-1022

2005

  1. Proteome analysis of a human uveal melanoma primary cell culture by 2-DE and MS

    Proteomics, Vol. 5, Núm. 18, pp. 4980-4993

2004

  1. Abnormal cell cycle regulation in primary human uveal melanoma cultures

    Journal of Cellular Biochemistry, Vol. 93, Núm. 4, pp. 708-720